InMed’s President and CEO, Eric A. Adams, presents at the 2021 Benzinga Cannabis Capital Conference from October 14-15.
In this presentation, Mr. Adams talks about InMed’s cannabinoid manufacturing, pharmaceutical programs in epidermolysis bullosa and glaucoma, and the acquisition of BayMedica, a rare cannabinoid manufacturing company. He explains how the acquisition transforms InMed into a revenue-generating company and global leader in the manufacturing and development of rare cannabinoids.
The Benzinga Cannabis Capital Conference is the premier gathering of cannabis entrepreneurs and investors in North America. The conference features an interactive forum of live and On-Demand presentations from top CEOs, investors, and leaders in the cannabis space from across the globe.
